Qiaoli Shi

657 total citations · 1 hit paper
23 papers, 398 citations indexed

About

Qiaoli Shi is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Qiaoli Shi has authored 23 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Complementary and alternative medicine. Recurrent topics in Qiaoli Shi's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Natural Compounds in Disease Treatment (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Qiaoli Shi is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Natural Compounds in Disease Treatment (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Qiaoli Shi collaborates with scholars based in China, Singapore and Macao. Qiaoli Shi's co-authors include Jigang Wang, Fei Xia, Qiuyan Guo, Chengchao Xu, Chong Qiu, Junzhe Zhang, Yuqing Meng, Huan Tang, Huanhuan Pang and Chen Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Molecules.

In The Last Decade

Qiaoli Shi

22 papers receiving 393 citations

Hit Papers

Advanced Strategies for Overcoming Endosomal/Lysosomal Ba... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaoli Shi China 10 199 60 51 47 41 23 398
Shatrunajay Shukla India 9 225 1.1× 45 0.8× 69 1.4× 31 0.7× 24 0.6× 23 577
Xinjun Cai China 12 181 0.9× 49 0.8× 60 1.2× 46 1.0× 50 1.2× 44 414
Xinwen Zhou China 14 417 2.1× 40 0.7× 71 1.4× 22 0.5× 29 0.7× 37 608
Peiliang Shen China 13 228 1.1× 38 0.6× 123 2.4× 45 1.0× 24 0.6× 23 485
Geng Zhang China 14 249 1.3× 55 0.9× 25 0.5× 19 0.4× 34 0.8× 39 638
Subhadip Das India 15 198 1.0× 33 0.6× 31 0.6× 18 0.4× 49 1.2× 39 567
Fanbo Jing China 13 274 1.4× 35 0.6× 57 1.1× 63 1.3× 25 0.6× 33 489
Wei Duan China 10 170 0.9× 92 1.5× 35 0.7× 36 0.8× 11 0.3× 17 419
Ayodeji Mathias Adegoke Nigeria 9 213 1.1× 33 0.6× 48 0.9× 25 0.5× 23 0.6× 26 607

Countries citing papers authored by Qiaoli Shi

Since Specialization
Citations

This map shows the geographic impact of Qiaoli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaoli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaoli Shi more than expected).

Fields of papers citing papers by Qiaoli Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaoli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaoli Shi. The network helps show where Qiaoli Shi may publish in the future.

Co-authorship network of co-authors of Qiaoli Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaoli Shi. A scholar is included among the top collaborators of Qiaoli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaoli Shi. Qiaoli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Guanjun, Ling Huang, Peili Wang, et al.. (2025). Activity-based chemical proteomics reveals caffeic acid ameliorates pentylenetetrazol-induced seizures by covalently targeting aconitate decarboxylase 1. Cell Communication and Signaling. 23(1). 62–62. 2 indexed citations
2.
Yao, Hua-Dong, Ling Huang, Ying Liu, et al.. (2025). Engineering anti-inflammatory magnesium-mangiferin hydrogel for diabetic wound healing. Materials & Design. 258. 114650–114650. 1 indexed citations
3.
Zhu, Yinhua, Ying Zhang, Ping Song, et al.. (2025). Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice. Exploration. 5(6). 20240069–20240069.
4.
Chen, Jiayun, Qian Zhang, Piao Luo, et al.. (2024). STEP: profiling cellular-specific targets and pathways of bioactive small molecules in tissues via integrating single-cell transcriptomics and chemoproteomics. Chemical Science. 15(12). 4313–4321. 6 indexed citations
5.
Zhang, Ying, Chen Wang, Huan Tang, et al.. (2024). Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model. Phytomedicine. 129. 155657–155657. 7 indexed citations
6.
Gao, Peng, Jianyou Wang, Chong Qiu, et al.. (2024). Photoaffinity probe‐based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum. SHILAP Revista de lepidopterología. 3(2). e176–e176. 5 indexed citations
7.
Shen, Shengnan, Qiwen Liao, Liwei Gu, et al.. (2024). G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases. SHILAP Revista de lepidopterología. 3(1). 3 indexed citations
8.
Qiu, Chong, et al.. (2023). Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes. Materials Today Nano. 25. 100442–100442. 4 indexed citations
9.
Li, Jinglin, Qiaoli Shi, Yin Kwan Wong, et al.. (2023). Quantitative Chemical Proteomics Reveals Triptolide Selectively Inhibits HCT116 Human Colon Cancer Cell Viability and Migration Through Binding to Peroxiredoxin 1 and Annexin A1. Advanced Biology. 8(10). e2300452–e2300452. 2 indexed citations
10.
Qiu, Chong, Fei Xia, Junzhe Zhang, et al.. (2023). Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. Research. 6. 148–148. 119 indexed citations breakdown →
11.
Meng, Yuqing, Jiayun Chen, Yanqing Liu, et al.. (2022). A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers. Journal of Pharmaceutical Analysis. 12(6). 879–888. 23 indexed citations
12.
Zhang, Qian, Piao Luo, Jiayun Chen, et al.. (2022). Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics. International Journal of Biological Sciences. 18(5). 2003–2017. 43 indexed citations
13.
Gao, Peng, Yanqing Liu, Wei Xiao, et al.. (2022). Identification of antimalarial targets of chloroquine by a combined deconvolution strategy of ABPP and MS-CETSA. Military Medical Research. 9(1). 30–30. 19 indexed citations
14.
Shi, Qiaoli, Fei Xia, Qixin Wang, et al.. (2022). Discovery and repurposing of artemisinin. Frontiers of Medicine. 16(1). 1–9. 42 indexed citations
16.
Liu, Dandan, Qian Zhang, Piao Luo, et al.. (2022). Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. Aging and Disease. 13(3). 815–815. 27 indexed citations
17.
Luo, Piao, Jiayun Chen, Junzhe Zhang, et al.. (2022). 18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs. Journal of Pharmaceutical Analysis. 12(4). 570–582. 36 indexed citations
18.
Zhang, Ying, Qianyu Zhang, Lin Chen, et al.. (2022). Oridonin acts as a novel senolytic by targeting glutathione S-transferases to activate the ROS-p38 signaling axis in senescent cells. Chemical Communications. 58(95). 13250–13253. 10 indexed citations
20.
Shi, Qiaoli, et al.. (2017). [Quality of realgar and its influencing factors based on toxicity].. PubMed. 42(24). 4782–4787. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026